For informational purposes only — not investment advice

← Back to signals

AKAM

LONGINSIDER SELLCONGRESS BUY

AKAMAI TECHNOLOGIES INC

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.

Funds
3
Score
2.58
vs SPY
-10.8%
Stock return (since Q-end)
+8.8%
SPY return (since Q-end)
+19.7%
Current price
$124.99
Days to cover (short int.)
6.1d↑+0.3%
as of 2026-07-31

News Summary

Neutral

Akamai delivered solid earnings beats in Q1-Q2 2026 with accelerating Cloud Infrastructure Services growth (39-40% YoY), driven by major AI infrastructure contracts including a landmark $1.8B deal and a new $600M robotics contract. However, the company faces significant near-term headwinds: margin compression to mid-20s, capital intensity at ~40% of revenue, paused buybacks, and a $0.12 EPS dilution from the LayerX acquisition, while guidance reflects only modest 5-6% near-term growth despite management's projection of low-teens acceleration in 2027.

Red flags

  • Non-GAAP net income declined 8% YoY in Q2 despite revenue growth, signaling margin pressure
  • Operating margins contracted significantly (GAAP diluted EPS fell 27% in Q2)
  • Capital expenditures projected at ~40% of revenue for 2026, constraining free cash flow and necessitating pause in share repurchases
  • LayerX acquisition expected to dilute 2026 EPS by $0.12 with no meaningful revenue contribution
  • Near-term revenue guidance of only 5-6% growth conflicts with investment thesis; major $600M robotics deal will not materially contribute until 2027

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Point72Steve Cohen3.3M+733K$379M<0.1%+29%Existing
Sachem Head CapitalScott Ferguson235K+235K$27M0.7%NEW
Glenview CapitalLarry Robbins156K+156K$18M0.5%NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where AKAM ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Point72

position #14 of this fund's book

  1. 11META PLATFORMS INC$520M
  2. 12SPOTIFY TECHNOLOGY S A$444M
  3. 13RTX CORPORATION$395M
  4. 14AKAMAI TECHNOLOGIES INC$379M
  5. 15BLOCK INC$379M
  6. 16MKS INC.$370M
  7. 17HOME DEPOT INC$369M
Sachem Head Capital

position #19 of this fund's book

  1. 16Bitdeer Technologies Group$83M
  2. 17Invesco Exchange Traded FD T$38M
  3. 18Sprinklr Inc$34M
  4. 19Akamai Technologies Inc$27M
Glenview Capital

position #37 of this fund's book

  1. 34SURGERY PARTNERS INC$21M
  2. 35DIGITALOCEAN HLDGS INC$21M
  3. 36BAKER HUGHES COMPANY$19M
  4. 37AKAMAI TECHNOLOGIES INC$18M
  5. 38INTEL CORP$18M
  6. 39BIOGEN INC$10M
  7. 40PRIMO BRANDS CORPORATION$10M

Values are quarter-end position sizes. Shown only for funds where AKAM ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Signal History

QuarterDirectionFundsScorevs SPY
Q2 2026SHORT31.89-9.0%
Q1 2026LONG32.58-10.8%

Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Joseph Paul CEVP - Global SalesSELL3K$126.77$0.39M2026-07-15
Blumofe RobertChief Technology OfficerSELL243$129.41$0.03M2026-06-18
Salem-Jackson KimEVP, Chief Marketing OfficerSELL2K$135.57$0.31M2026-06-10

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
BlackRock, Inc.SC 13G/A10.0M7.0%2026-01-21

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan ArmstrongsenateBUY$1,001 - $15,0002026-03-272026-07-21

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.